NCT07819422

Brief Summary

Physical exercise acts as a major physiological stressor that alters cardiovascular and autonomic homeostasis. Catestatin (CTS), a bioactive peptide derived from chromogranin A (CgA), acts as a potent inhibitor of catecholamine secretion and modulates autonomic cardiovascular tone. However, the acute effects of distinct exercise modalities on circulating CTS dynamics and their associations with post-exercise autonomic recovery remain unclarified. The purpose of this study is to investigate the acute responses of serum catestatin and chromogranin A to high-intensity interval training (HIIT) versus moderate-intensity continuous training (MICT) in healthy sedentary young males, and to evaluate their potential relationship with post-exercise heart rate recovery (HRR). Participants completed an initial incremental performance test followed by either a single HIIT session or a MICT session on a cycle ergometer. Serial blood samples and continuous cardiovascular measurements were obtained before, immediately after, and throughout a 60-minute post-exercise recovery period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at P25-P50 for not_applicable healthy-volunteers

Timeline
Completed

Started Oct 2025

Shorter than P25 for not_applicable healthy-volunteers

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 24, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 5, 2026

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 9, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 15, 2026

Completed
Last Updated

September 15, 2026

Status Verified

July 1, 2025

Enrollment Period

3 months

First QC Date

September 9, 2026

Last Update Submit

September 9, 2026

Conditions

Keywords

CatestatinChromogranin AHigh-intensity interval trainingModerate-intensity continuous trainingHeart rate recoveryParasympathetic reactivation

Outcome Measures

Primary Outcomes (1)

  • Serum Catestatin Concentration

    Serum catestatin levels measured using enzyme-linked immunosorbent assay (ELISA) to evaluate acute exercise-induced dynamic responses.

    Baseline (pre-exercise), immediately post-exercise (0 min), and at 15, 30, 45, and 60 minutes post-exercise.

Secondary Outcomes (2)

  • Serum Chromogranin-A Concentration

    Baseline (pre-exercise), immediately post-exercise (0 min), and at 15, 30, 45, and 60 minutes post-exercise.

  • Post-Exercise Heart Rate Recovery (HRR1 and HRR5)

    At 1 minute and 5 minutes post-exercise.

Study Arms (2)

High-Intensity Interval Training (HIIT)

EXPERIMENTAL

Participants completed an acute HIIT session on a cycle ergometer consisting of a 5-minute warm-up, followed by four 4-minute bouts at 85-95% of maximum heart rate (HRmax) interleaved with 3-minute active recovery periods, followed by a 5-minute cool-down.

Other: High-Intensity Interval Exercise

Moderate-Intensity Continuous Training (MICT)

EXPERIMENTAL

Participants completed an acute MICT session on a cycle ergometer consisting of a 5-minute warm-up, followed by 30 minutes of continuous cycling at 60-70% of maximum heart rate (HRmax), followed by a 5-minute cool-down.

Other: Moderate-Intensity Continuous Exercise

Interventions

Acute bout of 4x4 min intervals at 85-95% HRmax with 3 min active recovery on a cycle ergometer.

High-Intensity Interval Training (HIIT)

Acute bout of continuous cycling for 30 minutes at 60-70% HRmax on a cycle ergometer.

Moderate-Intensity Continuous Training (MICT)

Eligibility Criteria

Age18 Years - 25 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy male individuals aged 18-25 years
  • Body mass index (BMI) between 18.0 and 25.0 kg/m²
  • Sedentary lifestyle (no regular exercise engagement within the last 3 months; \<90 min/week moderate-intensity or \<60 min/week vigorous-intensity exercise)
  • Normal resting blood pressure (\<140/90 mmHg)
  • Fasting plasma glucose between 60 and 100 mg/dL
  • Normal resting electrocardiogram (ECG) and pulmonary function tests (FEV1/FVC \>80%)
  • Signed written informed consent

You may not qualify if:

  • Regular smoking or alcohol consumption
  • Any current or regular medication use
  • History or clinical signs of cardiovascular, respiratory, metabolic, or renal diseases
  • Symptoms suggestive of cardiopulmonary/metabolic disease (chest pain, shortness of breath, dizziness, syncope, ankle edema, palpitations, intermittent claudication)
  • Presence of known cardiovascular risk factors
  • Iron deficiency / anemia
  • Musculoskeletal limitations or contraindications to maximal cycle ergometer testing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Firat University Medical Faculty, Department of Physiology

Elâzığ, Elâzığ, 23119, Turkey (Türkiye)

Location

MeSH Terms

Interventions

High-Intensity Interval Training

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: A two-arm parallel-group design comparing acute high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) in sedentary young males.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

September 9, 2026

First Posted

September 15, 2026

Study Start

October 24, 2025

Primary Completion

January 10, 2026

Study Completion

March 5, 2026

Last Updated

September 15, 2026

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

De-identified individual participant data that underlie the results reported in this article will be shared with researchers upon reasonable request directed to the corresponding author.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Beginning immediately following publication with no end date.
Access Criteria
Data will be shared for non-commercial academic research purposes upon written request to the corresponding author.

Locations